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Introduction: Migraine attacks associated with menstruation are generally perceived as
more severe than attacks outside this period.
Aim and Objective: The study aimed at determining the frequency of menstrual-related
headaches among a cohort of senior secondary school girls in Abeokuta, Nigeria. We also
determined its burden among these school girls.
Methodology: This study was cross-sectional using a validated adolescent headache survey
questionnaire. A self-administration of the instrument was done during a school visit.
A headache was classified using the ICHD-II criteria.
Results: Of the 183 students interviewed, 123(67.2%) had recurrent headaches. Mean age
±SD, 16.18±1.55 (range 12–19). The prevalence of definite migraine was 17.5% while the
prevalence of probable migraine was 6.0%. The prevalence of tension-type headache was
41.0%. Migraine was significantly menstrual-related (p=0.001, 95% CI=1.06–6.63). Median
pain severity score was higher among MRH group (p=0.043). The median number of days of
reduced productivity and missed social activities was significantly higher in the MRH group;
p= 0.001 and p=0.03, respectively. Subjects with MRH were more incapacitated by their
headaches (p= 0.003).
Conclusion: Menstrually related headache is prevalent even among the adolescent and it
has adversely affected their productivity and social life. Care of adolescent with headaches
should be intensified.
Keywords: headache, adolescence, migraine, menstruation, menstrually related
Introduction
Over 37 million Nigerians are adolescents (between the ages of 10–19 years) and
they constitute over 20% of the general population. Roughly half of these are
females.1 Adolescence is a phase of life characterized by rapid and ample physical,
biological, psychosocial and neurodevelopmental changes 2 One of the biological
changes that characterize this period is the attainment of menarche; a milestone that
is greatly influenced by the genetic makeup and environmental factors of the
individual and one that is accompanied by menstrually associated disorders3 apart
from other psychosocial issues. The adolescent population is therefore faced with
specific health and developmental needs.
Migraine headache, the 7th disabling disease4 is probably as common among
the adolescent population as in the adult5 although our current understanding of
headache pathophysiology among children and adolescents is based on extrapola-
tions from studies conducted among adults.6 Migraine is twice as prevalent in
females as in male genders especially after puberty. Among adolescents just like
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in adults, chronic migraine has been found to be strongly
associated with depression, irritability, missed school/
works as well as missed social activities thereby increasing
the total burden of headaches in this population.7
Menstrual disorders have been found to be significant
among adolescents who reported headache or dizziness
during their menstrual period.8
According to the international classification of headache
disorders 2nd version (ICHD-II),9 menstrually related
migraine (MRM) is defined as attacks of menstrually related
migraine without aura that has an onset during the peri-
menstrual time period (2 days before to 3 days after the
onset of menstruation) and this pattern must be confirmed in
two-thirds of menstrual cycles, but other attacks may occur
at other times of the menstrual cycle (Table 1). Migraine
attacks associated with menstruation are generally perceived
as more severe, more disabling and refractory to abortive
medications than those outside this period.10
There is paucity of data-driven scientific reports from
sub-Saharan African on the burden of menstrually related
migraine, especially among adolescents. The need for
individualized therapy, provision and optimization of
effective abortive therapy and improvement in the overall
quality of life of adolescent migraineurs calls for this
survey. We hypothesized that menstrually related head-
aches will be prevalent among Nigerian high school ado-
lescent girls. Our study aimed therefore, at determining the
frequency of menstrually related headaches among
a cohort of senior secondary school girls in Abeokuta,
southwestern Nigeria. We also set out to document head-
ache burden among these school girls.
Methodology
This was a cross-sectional observational study that was
conducted in four secondary schools in Abeokuta south
local government area (LGA), Abeokuta, south-western
Nigeria in October 2010. Abeokuta is a southwestern
Nigerian city with a population of 593,100 according to
the 2006 census. It is situated at elevation 64 m above sea
level and lies in longitude 3.35and latitude 7.16.11
Abeokuta is made up of two local governments namely
Abeokuta south and Abeokuta north LGA. Abeokuta south
was selected for the study by balloting. Of the 20 public
secondary schools in the local government, four secondary
schools (20%of the sample frame) were randomly selected
for the survey.
To obtain the lifetime prevalence of migraine and tension-
type headache from this adolescent population, the minimum
sample size to be studied was estimated to be 142. This was
based on a standard normal deviate of 1.96 and a degree of
accuracy of 0.05 while the proportion of high school students
with migraine was put at 10.3% based on a previous study
among Nigerian undergraduates.12 The study protocol was
approved by the research and ethics committee (REC) of
Federal Medical Centre Abeokuta (FMCA). The authorities
of the secondary schools approved the study and informed
verbal consent was obtained from the participants. Individual
parental informed consent was not obtained. The school
authority served as proxy for the parents in this regard. This
modification of the protocol was approved by the REC of
FMCA. Avalidated self-administered headache questionnaire
developed by Ojini et al13 was used for the survey. The
questionnaires were anonymized while the students were
assured of the confidentiality of their responses. The question-
naire were distributed to the participants by the residents
rotating through the neurology unit of the medical department
of our hospital after a pilot study with 20 students showed
excellent clarity. The 29 item questionnaire is made up of three
sections.
The first section assessed socio-demographic vari-
ables. The second section evaluated headache-related
variables including the association of headache with
menstruation in the past 3 months. The third section
assessed headache disability using the migraine disabil-
ity assessment scale (MIDAS). The headache-related
items were developed to incorporate diagnostic items
for migraine and tension-type headaches according to
Table 1 ICHD-2 Diagnostic Criteria for Menstrual Migraine
Diagnostic Criteria for Pure Menstrual Migraine Without
Aura (A1.1.1)
A. Attacks, in a menstruating woman, fulfilling the criteria for migraine
without aura
B. Attacks that occur exclusively from days −2 to +3 of menstruation
in at least two out of three menstrual cycles and at no other times of
the cycle.
Diagnostic Criteria for Menstrually-Related Migraine
Without Aura (A1.1.2)
A. Attacks, in a menstruating woman, fulfilling the criteria for migraine
without aura
B. Attacks that occur exclusively from days −2 to +3 of menstruation
in at least two out of three menstrual cycles, and additionally at other
times of the menstrual cycle.
Notes: The first day of menstruation is day +1, and the preceding day is day −1; there is
no day 0. In ICHD-3, menstruation is considered to be endometrial bleeding resulting
from either the normal menstrual cycle or from the withdrawal of exogenous proges-
togens, as in the use of combined oral contraceptives or cyclical hormone replacement
therapy.9
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the International Classification of Headaches Disorders
(ICHD-II) classification.9 The survey was conducted in
trickles during school hours at the end of class from
October 1, 2010 to October 20, 2010. Although the
questionnaires were self- administered, the authors
were on hand to give clarifications where necessary.
Six hundred questionnaires were distributed in all. The
males had 350 questionnaires while 250 questionnaires
were distributed to the female students based on their
availability in the school on the day of interview. Sub-
analysis of the female respondents was performed for
this report.
Statistical Analysis
Statistical analysis was performed with Statistical
Package for the Social Sciences version 20.0.0 (SPSS
Inc., Chicago). Data were summarized and presented as
frequencies and percentages. Categorical data were com-
pared using chi-square test. Normally distributed numer-
ical variables were summarized as mean with standard
deviation and between groups comparison was per-
formed with student’s t-test. Skewed numerical data
were summarized with median (interquartile range) and
non-parametric Kruskal–Wallis test was used for
between group comparisons. The level of significance
was set at p<0.05.
Results
Characteristics of the Respondents and
Prevalence of Menstrually Related
Headaches
One hundred and eighty-three (183) out of the 250 ques-
tionnaires distributed to the female students were returned
(response rate 73.2%). Of the 183 respondents, 39 subjects
(21.3%) had headaches considered to be due to systemic
infection like malaria, typhoid or flu. Of those whose
headaches were not due to the factors above, 16 (8.7%),
had non-recurrent headaches. Five subjects who had recur-
rent headaches but were older than 19 years of age were
excluded from the analysis. Figure 1 shows the algorithm
of subjects’ selection for the analysis.
The prevalence of all primary headache type was
67.2% (123/183). Thirty-two subjects (17.5%) satisfied
the ICHD-II criteria for the diagnosis of migraine while
11(6.0%) satisfied the criteria for probable migraine. The
prevalence of Tension Type Headache (TTH) was 41.0%
(75/183). Five patients (2.7%) could not be classified.
The prevalence of menstrually related headache was
14.2% (26/183).The prevalence of definite menstrually
related migraine was 6.6% (12/183). When probable
migraine was added, the prevalence of all menstrually
related migraine was 8.7% (16/183). There was no signifi-
cant age difference between the cohorts with and without
Figure 1 Algorithm for screening for recurrent headaches among the subjects.
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menstrually related headaches (Table 2). Although the dif-
ference was also insignificant, subjects with menstrually
related headaches tend to have a positive family history of
headaches. Nausea and photophobia were significantly pre-
valent among subjects with menstrually related headaches
(p<0.05) and these subjects were more likely to consult
a doctor for their headaches (p<0.05). Table 2 shows the
baseline characteristics of those with recurrent headaches.
Table 3 shows the frequency of menstrually related primary
headaches. Migraine was significantly menstrually related
Table 2 Sociodemography and Baseline Characteristics of the Subjects
Variables All Primary
Headaches
sn=123 (100%)
Non-MRH n=97
(100%)
MRH n=26
(100%)
Test
Statistics
P value
Age
12–14 12(9.8) 9(9.3) 3(11.5) 1.90# 0.386
15–17 80(65.0) 66(68.0) 14(53.8)
18–19 31(25.2) 22(22.7) 9(34.6)
Family history of headaches 51(41.5) 38(39.6) 13(50.0) 0.91# 0.375
Frequency 5.89# 0.435
Daily 2(1.6) 2(2.1) 0(0.0)
3x/week 25(20.3) 20(20.8) 5(20.0)
2x/week 16(13.0) 14(14.6) 2(8.0)
1/week 19(15.4) 15(15.6) 4(16.0)
2x/month 15(12.2) 12(12.5) 3(12.0)
1/month 21(21) 13(13.5) 8(32.0)
3–6/year 23(18.7) 20(20.8) 3(12.0)
Severity of Pain on VAS, Median
(IQR)
5.0(10.0) 2.0(10.0) 5.5(8.25) 930† 0.185
Presence of nausea 21(17.1) 12(12.5) 9(36.0) 7.64# 0.006*
Presence of photophobia 41(33.3) 30(31.9) 11(42.3) 0.98# 0.323
Presence of phonophobia 89(72.4) 64(66.7) 25(96.2) 9.02# 0.003*
Consultation
Consult a doctor 43(35.0) 29(30.9) 14(53.8) 4.68# 0.030*
Self-medication 75(61.0) 55(59.1) 20(76.9) 2.76# 0.097
Prayers 10(8.1) 8(8.2) 2(7.8) – –
Frequently used medication
Aspirin 3(2.4) 2(2.1) 1(3.8) – –
PCM 83(67.5) 66(68.0) 17(65.4) – –
Other NSAID 6(4.9) 4(4.1) 2(7.7) – –
Sedative 3(2.4) 1(1.03) 2(7.7) – –
Notes: #Chi-Square Test; †Mann–Whitney U-Test;*Significant value (P< 0.05).
Table 3 Frequency of Primary Headache and Its Association with Menstruation
Non MRH n=97(100) MRH n=26(100) χ2 RR (95% CI) P value
Migraine 20(20.6) 12(46.2) 6.95 3.30(1.32–8.24) 0.008*
Probable migraine 7(7.2) 4(15.3) 1.68 2.34(0.63–8.69) 0.195
All migraine 27(27.8) 16(61.5) 10.24 2.65(1.06–6.63) 0.001*
TTH 66(68.04) 9(34.6) 9.63 0.25(0.10–0.62) 0.002*
Unclassifiable 4(4.1) 1(3.5) 1.00ǂ 1.06(0.18–6.33) 0.715
Notes: ǂFishers exact chi–square; *Significant value (P< 0.05).
Abbreviation: TTH, tension-type headache.
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(p=0.001, 95% CI=1.06–6.63) while TTH was significantly
non-menstrually related (p=0.007, 95% CI=1.25–5.32).
Burden of Menstrually Related Headaches
When severity of headaches was compared across age
groups, there was a significantly higher median head-
ache severity score among 18–19 years old with men-
strually related headaches (p=0.034). (Figure 2).No
statistically significant difference in median headache
severity scores was noted between those with or without
menstrually related headache in the other age groups
(Figure 2).
Table 4 shows the comparison of each item of the
MIDAS scale between subjects with and without menstru-
ally related headaches. Median number of days of missed
social activities and reduced productivity was significantly
higher among the cohort with menstrually related
headaches; p-values 0.047 and 0.004, respectively. There
was no difference in the median number of days of missed
social activities, reduced productivity or reduced house
works between the cohort of menstrually related migraine
and other menstrually related headaches. The cohort with
menstrually related migraine, however, demonstrated more
severe headaches (p value =0.006) as well as more number
of headache days in the last three months (p value=0.007).
Table 5 shows the degree of headache disability
according to the total MIDAS score. A score of 0–5 was
graded as little or no disability (grade I), 6–10 as mild
disability (grade II), 11–20 as moderate disability (grade
III) while >20 was defined as severe disability (grade IV).
Significantly higher proportion of patients with menstru-
ally related headaches had moderate disability (p=0.003).
Discussion
Research on small and specific populations of headache
sufferers has the added advantage of aiding in the identifi-
cation of factors that influence the frequency and severity
of various subtypes of headache13 thereby enabling effec-
tive planning and organization of health services. From
a planning point of view, gender-specific data, from clin-
ical and epidemiological studies have the potential to
bridge the knowledge gap that fosters the neglect of vul-
nerable groups such as adolescents.
Globally, the estimated overall mean prevalence of
headache among adolescents is 54.4% (95% CI 43.1–65.8)
and the overall mean prevalence of migraine is 9.1% (95%
CI 7.1–11.1).14 Among this cohort of female adolescents,
the prevalence of headache was 67.2%.14,15 Our study
found a higher prevalence compared to the study by
Ofovwe and Ofili who reported a prevalence of 19.5% in
a survey of secondary school students in south-south
Nigeria.16 Ofovwe and Ofili, however, reported a migraine
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Figure 2 Clustered bar charts showing severity of headaches in subjects with and
without menstrual headaches. *significant value (P<0.05).
Table 4 Comparison of MIDAS Items Between Patients with and Without MRH and MRM
Variables, Median (IQ-Range) Non-MRH (n=97) MRH
(n=26)
P value Non-MRM(21) MRM (11) P value
Days of missed school/work 0.0(1.0) 0.0(0.5) 0.669 0.0(1.0) 0.0(1.0) 0.984
Days of reduced productivity (work/school) 0.0(2.0) 0.0(1.3) 0.830 0.0(3.5) 0.0(2.0) 0.631
Days of missed social activities 0.0(2.0) 2.0(3.3) 0.047* 0.0(2.0) 0.0(2.0) 0.861
Days of reduced productivity (housework) 0(2.0) 2.0(5.5) 0.004* 0.0(2.5) 1.0(5.0) 0.715
Days of missed house works 1.0(3.0) 0.5(3.0) 0.393 1.0(3.0) 3.0(4.0) 0.108
Headaches days/3 months 0.0(4.0) 2.0(5.5) 0.650 2.0(2.0) 5.0(4.0) 0.006*
Pain Severity 2.0(10.0) 6.0(7.5) 0.323 3.0(9.75) 10.0(7.5) 0.007*
Note: *Significant value (P< 0.05).
Abbreviations: MRH, menstrually related headaches; MRM, menstrually related migraine.
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prevalence of 13.5% which is comparable to the prevalence
rate of 11.5% that we found in this study. As pointed out by
Wöber-Bingöl, there is a paucity of population-based stu-
dies of adolescent headaches from low and low-middle
income countries15 hence there are limited studies to com-
pare our findings with. When compared with studies among
young undergraduates, our study found a higher prevalence
of headache than Mitsicostas as et, who reported
a prevalence of 50.3% among female undergraduate.14
Krogh et al17 however, reported a prevalence of 88%;
a rate higher than what we found in this cohort. The rela-
tively modest sample size in our study as well as regional/
racial differences in headache epidemiology could have
been responsible for these differences even though we
used the same diagnostic criteria as the earlier quoted stu-
dies. The prevalence rate in this study is however compar-
able to the prevalence rate of 62.8% in the female cohorts of
the survey by Ojini et al in a sample of Nigerian
undergraduates.13
The prevalence of menstrually related headache was
14.2% in this survey of which menstrually related
migraine was 8.7% when all migraine (definite and prob-
able migraine) was summed up. Among the female adult
population, the prevalence of menstrually related migraine
without aura ranges from 20-51% while that of pure men-
strual migraine without aura varies from 7-19%.18,19 There
is paucity of literature on menstrually related migraine in
adolescents. In a study of 896 girls between 9 and 18
years, Crawford et al reported a prevalence rate of
36.9%.20 This value no doubt is higher than what we
found. While the value of Crawford et al approaches that
of the female adult population, the prevalence of MRM in
this study lags behind that of the female adult population
as well as that of the Caucasian adolescent population.
This finding suggests that perhaps the adolescent
Caucasian or African American adolescents attain
menarche earlier, and that their hypo-thalamo-pituitary-
ovarian (HPO)functions mature faster than native African
adolescents.
By way of pathophysiology, the decline in serum estradiol
levels that occur soon before and during the peri-menstrual
time period is the most plausible trigger for menstrual
migraine. Other contributor to MM includes the release of
prostaglandins from a shedding endometrium that sensitizes
peripheral nociceptors, and the declines in serum magnesium
levels. A decrease in the inhibitory neurotransmitter systems
that modulate neuronal firing rates within second-order neu-
rons of the trigeminal system may also augment the initiation
of MM.21 Therefore, the more developed the HPO function is,
the more readily the adult pattern of menstruation is estab-
lished. The above hypothesis is buttressed by our findings of
higher median pain severity score among older girls aged
18–19 years (Figure 2). This relatively higher pain severity
score also agrees with the finding of Stewart et al22 who in
a rigorous prospective survey of 81 migraineurs women from
the general population, found a slight increase in the severity
of attacks occurring the first 2 days of menses. However, these
authors did not find any other significant characteristical dif-
ference between menstrual and non-menstrual migraine
attacks.
A significant proportion of adolescents with MRH
sought a doctor for their headaches (Table 1). Although
the difference was not significant, the MRH cohort was
more likely to self-medicate. It is possible that this treat-
ment-seeking pattern is dictated by the severity of the
headache attacks. We recorded no use of abortive therapies
such as triptans and ergot preparations in this study. Our
finding mirrors the report by other authors in our
environment.12,13,16,23 Oshinaike et al, also recorded no
patient with triptans prescription, but up to 32% of those
who sought medical consultation had ergot prescription.23
The study population (hospital staff members) however
was not comparable with ours hence the difference in the
treatment pattern. Our finding clearly underscores the fact
that headaches in general, are undertreated in our environ-
ment and menstrually related headaches in particular, does
not enjoy any special attention as far as treatment is
concerned.
Table 5 Headache Disability in Relation to Menstruation
MIDAS Scale Overall (n=123) Non-MRH (n=97) MRH (n=26) χ2 OR 95% CI P-value
Grade I 42(34.1) 37(38.1) 5(19.2) 3.26 0.37 0.13–1.11 0.071
Grade II 17(13.8) 16(16.5) 1(3.8) 2.75 0.20 0.03–1.60 0.097
Grade III 26(21.1) 15(15.4) 11(42.3) 8.86 4.01 1.55–10.39 0.003*
Grade IV 38(30.9) 29(29.8) 9(34.6) 0.21 1.24 0.50–3.11 0.644
Note: *Significant value (P< 0.05).
Abbreviations: MRH, menstrually related headaches; MRM, menstrually related migraine; MIDAS, migraine disability assessment scale.
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Our results show that menstrually related headaches are
clearly more disabling especially when moderate to severe
disability are considered. Crawford et al20 found no differ-
ence in disability between girls with a menstrual pattern and
those without a menstrual pattern although girls with MM
reported increased associated symptoms compared with girls
without MM. In our cohort, however, girls with MM reported
more headache days in 3 months and higher pain severity
suggesting that girls with MM are likely more incapacitated
by their headaches. Just like we have established, the
American Migraine Prevalence and Prevention (AMPP)
study found that women with MM were more impaired by
attacks while women with MAM had overall highest burden,
likely due to experiencing migraines on additional days.24
Limitations and Strength of Study
Our study is limited by its modest sample size and cross-
sectional design. However, its strength lies in the fact that
there is paucity of MRH-specific data from SSA. In addi-
tion, we have studied a population of educated/enlightened
girls; hence, the influence of cultural beliefs on reporting
MRH is less likely.
Conclusion
Our study found that menstrually related headache is pre-
valent among adolescent Nigerian girls. When compared
with similar studies among whites, it appears less prevalent
but undoubtedly more disabling. Unfortunately, health-care
facilities are poorly accessed and the headache is poorly
treated in that approved medications are seldom used by
the migraineurs. More headache education and awareness
programs need to be instituted and possibly incorporated
into adolescent and school health programs. Headache advo-
cacy among this vulnerable group should be escalated as this
might have a long-lasting impact on reducing the burden of
menstrually related headaches in our environment.
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